Imperative Care announced today that it completed enrollment in the SYMPHONY-PE pivotal investigational device exemption (IDE) study. The FDA IDE study evaluates the company's Symphony Thrombectomy System for treating acute pulmonary embolism … [Read More...] about Imperative Care completes enrollment in pulmonary embolism study
Main Content
Medical Tubing & Extrusion
Imperative Care completes enrollment in pulmonary embolism study
Imperative Care announced today that it completed enrollment in the SYMPHONY-PE pivotal investigational device exemption (IDE) study. The FDA IDE study evaluates the company's Symphony Thrombectomy System for treating acute pulmonary embolism … [Read More...] about Imperative Care completes enrollment in pulmonary embolism study
Imperative Care expands Zoom Stroke System with new dual-catheter launch
Imperative Care announced today that it expanded its Zoom Stroke System with the launch of its Zoom DuoPort technology. Zoom DuoPort allows physicians to continue using the novel continuous dual-aspiration technique (CDAT) on two Zoom aspiration … [Read More...] about Imperative Care expands Zoom Stroke System with new dual-catheter launch
FastWave Medical earns nod to begin IVL feasibility study
FastWave Medical announced today that it received Institutional Review Board (IRB) approval to begin a coronary feasibility study. The study utilizes Sola, the company's novel laser intravascular lithotripsy (IVL) system. FastWave partnered with … [Read More...] about FastWave Medical earns nod to begin IVL feasibility study
Boston Scientific completes SoniVie acquisition
Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] announced today that it completed its previously announced acquisition of SoniVie. In March, Boston Scientific announced that it agreed to acquire the intravascular ultrasound … [Read More...] about Boston Scientific completes SoniVie acquisition
Route 92 Medical settles patent spat with Q’Apel
Route 92 Medical announced today that it settled the patent litigation filed against Q’Apel Medical over delivery catheter intellectual property. San Mateo, California–based Route 92 develops a suite of reperfusion and access systems leveraging … [Read More...] about Route 92 Medical settles patent spat with Q’Apel
Endospan has positive aortic arch stent graft study results
Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system. Results came out of the statistical dissection primary arm from the TRIOMPHE FDA investigational device exemption (IDE) … [Read More...] about Endospan has positive aortic arch stent graft study results
Orchestra BioMed wins FDA IDE for sirolimus-angioballoon
Orchestra BioMed (Nasdaq:OBIO) announced today that it received FDA investigational device exemption (IDE) for its Virtue drug-coated balloon. It marks the second major regulatory milestone for Orchestra BioMed in just a week. The company last … [Read More...] about Orchestra BioMed wins FDA IDE for sirolimus-angioballoon
